In a Hirschsprung disease mouse model, diet shifted gut microbes and inflammation, with a 3-fold survival difference between standard diets.
|Videos|May 26, 2022
Donna Hallas on formula shortage: breastfeed if able, contact pediatricians, do not hoard
Author(s)Katie Hobbins
Donna Hallas, a Contemporary Pediatrics® Editorial Advisory Board member, discusses the infant formula shortage.
Advertisement
In a video for Contemporary Pediatrics®, Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, gives advice on what to do during the current formula shortage, from advocating for breastfeeding when possible to not hoarding product.
Advertisement
Related to this article
A national claims analysis found 16.8% of pediatric GLP-1 users developed a nutritional deficiency within a year, most often vitamin D, while few received nutritional counseling.
A Bifidobacterium-based synbiotic was well tolerated and increased colonization of administered strains in infants and toddlers.
Pediatricians can help teen athletes navigate sports supplements by prioritizing nutrition and identifying products to support, limit, or avoid.
Semaglutide plus lifestyle changes moved 40.4% of children below the obesity threshold at 68 weeks in the phase 3 STEP Young trial.
Persephone's ARTEMIS trial found its Bifidobacterium-HMO synbiotic safe and effective at gut colonization in 114 infants and toddlers.
A content analysis of 159 picture books found food often symbolized family connection and culture more than nutrition alone, according to Carol Duh-Leong, MD, MPP.
The AAP's updated clinical report revises screening timelines, ferritin thresholds, and treatment protocols for pediatric iron deficiency and iron deficiency anemia.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
BLA submitted to FDA for Viaskin peanut patch in children aged 4 to 7 years with peanut allergy
2
First-in-human trial tests microneedle stamp approach for peanut allergy
3
What the Camzyos approval means for adolescents with obstructive HCM
4
FDA approves tiratricol as first treatment for peripheral thyrotoxicosis in MCT8 deficiency
5